Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project

Sara Faghihi‐Kashani,Akira Yoshida,Francisca Bozan,Giovanni Zanframundo,Davide Rozza,Aravinthan Loganathan,Eduardo Dourado,Gianluca Sambataro,Iazsmin Bauer Ventura,Sangmee Sharon Bae,Darosa Lim,Daphne Rivero Gallegos,Yasuhiko Yamano,Albert Selva‐O'Callaghan,Andrew L. Mammen,Carlo A. Scirè,Carlomaurizio Montecucco,Chester V. Oddis,David Fiorentino,Francesco Bonella,Frederick W. Miller,Ingrid E. Lundberg,Jens Schmidt,Jorge Rojas‐Serrano,Marie Hudson,Masataka Kuwana,Miguel Angel González‐Gay,Neil McHugh,Tamera J. Corte,Tracy Jennifer Doyle,Victoria P. Werth,Latika Gupta,Diana Isabel Perez Roman,Lorenzo M. Bianchessi,Phani Kumar Devarasetti,Samuel Katsuyuki Shinjo,Fabrizio Luppi,Ilaria Cavazzana,Siamak Moghadam‐Kia,Marco Fornaro,Elizabeth R. Volkmann,Matteo Piga,Jesus Loarce‐Martos,Giacomo De Luca,Johannes Knitza,Veronica Wolff‐Cecchi,Marco Sebastiani,Adam Schiffenbauer,Lisa G. Rider,Raquel Campanilho‐Marques,Lucian Marts,Elena Bravi,Harsha Gunawardena,the CLASS project participating investigators,Rohit Aggarwal,Lorenzo Cavagna

DOI: https://doi.org/10.1002/art.43038

2024-10-30

Arthritis & Rheumatology

Abstract:Objective Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data‐driven classification criteria for ASSD. Methods We utilized a large, international, multi‐center "Classification Criteria for Anti‐synthetase Syndrome" (CLASS) project database, which includes both ASSD patients and controls with mimicking conditions, namely SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort. Results Our analysis included 948 ASSD cases and 1077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo‐1 and non‐Jo‐1 anti‐synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti‐Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/MRI/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between ASSD and controls or were inversely associated with ASSD. Conclusion We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data‐driven classification criteria for ASSD.

rheumatology